Teva Pharmaceutical Industries Ltd. decided to appoint Kera Schultz President and chief Executive officer of the company. About it reports a press-service of the company.
Schultz will replace on this post of Isaac of St. Petersburg, which will continue to perform the duties of the chief Executive officer before Schultz joined the company.
It is reported that Schultz will soon move to Israel to start working in the main office Teva in Petah Tikva.
Teva Pharmaceutical Industries Ltd. is the largest producer of generic medicines in the world. Teva’s net profit in 2016 amounted to $21,9 billion the Company operates in 80 countries around the world, including in Ukraine – since 1997
In December 2016, it was reported that Teva will have to pay a fine of $519 million to settle charges of bribing officials in several States.